ondansetron has been researched along with Rotavirus Infections in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Rotavirus Infections: Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagbom, M | 1 |
| Novak, D | 1 |
| Ekström, M | 1 |
| Khalid, Y | 1 |
| Andersson, M | 1 |
| Lindh, M | 1 |
| Nordgren, J | 1 |
| Svensson, L | 1 |
1 trial available for ondansetron and Rotavirus Infections
| Article | Year |
|---|---|
Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.
Topics: Adolescent; Antidiarrheals; Antiemetics; Child; Child, Preschool; Double-Blind Method; Female; Human | 2017 |